$ATRS - PDUFA October 20th for wholly owned testosterone injectible. Also has 4 other drugs up for FDA approval through partnerships between now and February 2018! Seems like a no brainer here. Phase 3 results for their drug were exceptional. Painless injection should become choice of treatment. Epipen replacement up for approval as well. Has an AB rating! Informative article on ATRS: https://finance.yahoo.com/news/atrs-milestones-continue-align-multiple-210000905.html I am long some November and February options.